Wolverine is a two-ingredient blend name; GLOW adds a copper-peptide component, and KLOW includes KPV as well. The exact formula still depends on the label. The number of ingredients and the total milligrams do not establish which blend works better.
Here is a concrete comparison using the three JD BioWorks listings checked November 10, 2026. These are examples of seller labels, not universal recipes or independently verified contents. PeptideWhy is an independent education site; the supplier links document the label claims.
Looking for amounts people reported using? Open the Wolverine reports, GLOW reports or KLOW reports to read each person’s amount and frequency together. The comparison below gives the labeled amount in the entire vial.
What is listed in each vial?
| Blend example | Labeled ingredients | Total and important distinction |
|---|---|---|
| Wolverine | BPC-157 5 mg + TB-500 5 mg. | 10 mg total. No GHK-Cu or KPV is listed. |
| GLOW | GHK-Cu 50 mg + BPC-157 10 mg + TB-4 10 mg. | 70 mg total. This listing says TB-4; do not silently replace that name with TB-500. |
| KLOW | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg. | 80 mg total. Confirm the exact thymosin form in the batch documentation. |
Label sources: Wolverine listing, GLOW listing and vial image, and KLOW listing. The table preserves the wording on those examples. It reports labeled quantities, not the supplier’s separate measured sample results.
Why does TB-4 versus TB-500 matter?
A study using thymosin beta-4 is not automatically a study of every product sold as TB-500. FDA’s safety page specifically identifies the thymosin beta-4 fragment LKKTETQ as also known as TB-500. Shortened fragments and the parent peptide should not be assumed identical from seller shorthand.
Ask which substance the label and laboratory method identify. If a product page, vial image and report use different names, the difference needs an explanation. Our TB-500 profile gives the broader context.
The same total amount is not the same ingredient amount
Label-arithmetic example only: imagine an evenly distributed 1 mg portion of each labeled mixture. This is not a dose recommendation, and a label cannot establish actual homogeneity or measured content.
- Wolverine 5/5: half the labeled mass is BPC-157, so 1 mg total would represent 0.5 mg BPC-157.
- GLOW 50/10/10: BPC-157 is 10/70 of the total, so 1 mg would represent about 0.143 mg BPC-157.
- KLOW 50/10/10/10: BPC-157 is 10/80 of the total, so 1 mg would represent 0.125 mg BPC-157.
The rule is: total portion × ingredient’s labeled mg ÷ total labeled mg. That is why a chart’s “1 mg” must identify whether it means one ingredient or the whole blend. The calculator converts entered amounts into liquid volume and syringe units; it does not choose a dose or prove that a vial matches its label.
Does adding ingredients improve the evidence?
The sources reviewed here do not establish that one of these finished blends produces better recovery, skin or gut outcomes than the others. Component findings answer narrower questions:
- BPC-157 with TB4: a 2021 knee-pain chart review reached 16 patients by phone; only four had received the combination, while 12 received BPC-157 alone. It was uncontrolled and did not use specific tools to measure function. It cannot show that a marketed Wolverine vial heals tendons or that the combination outperforms either ingredient. See our human injury-evidence review.
- KPV: the 2008 intestinal-inflammation study used cultured cells and mouse colitis models, including KPV in drinking water. It did not test injected KLOW in people. See the KPV gut-evidence guide.
- GHK-Cu: adding it changes the composition, but a finding from a topical or laboratory experiment would not establish the effects of an injected multi-ingredient vial. FDA describes limited human safety data for injectable GHK-Cu on the safety page above.
More ingredients also make an individual experience harder to interpret: if several substances are introduced together, timing alone cannot identify which caused a benefit or reaction. Reported experiences remain anecdotes, not a head-to-head trial.
Which page should I open next?
- For the specific product’s evidence and reported reactions: Wolverine, GLOW or KLOW.
- For what a laboratory report actually checks: Can a COA verify each ingredient?
- For the basic distinction between total vial mass and ingredient amounts: What is in a peptide blend?
These are research-use-only listing examples, not approved dosing instructions or evidence of a safe personal-use regimen. Sources and labels reviewed November 10, 2026. How we publish and correct sources →